Julie Brahmer

Professor

19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Julie Brahmer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

Open Access
Immunotherapy
Referral and Consultation
Neoplasms
Odds Ratio
Educational Models
Metformin
Platinum
Non-Small Cell Lung Carcinoma
Drug Therapy
Lymphopenia
Teaching Rounds
Medical Oncology
Immunotherapy

Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC

Antonia, S. J., Balmanoukian, A., Brahmer, J., Ou, S. H. I., Hellmann, M. D., Kim, S. W., Ahn, M. J., Kim, D. W., Gutierrez, M., Liu, S. V., Schöffski, P., Jäger, D., Jamal, R., Jerusalem, G., Lutzky, J., Nemunaitis, J., Calabrò, L., Weiss, J., Gadgeel, S., Bhosle, J. & 11 others, Ascierto, P. A., Rebelatto, M. C., Narwal, R., Liang, M., Xiao, F., Antal, J., Abdullah, S., Angra, N., Gupta, A. K., Khleif, S. N. & Segal, N. H., Oct 2019, In : Journal of Thoracic Oncology. 14, 10, p. 1794-1806 13 p.

Research output: Contribution to journalArticle

Open Access
Cell Death
Ligands
Safety
Disease-Free Survival
Pneumonia
Consultants
Oncogenes
T-Lymphocytes
Conflict of Interest
Organized Financing